We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ViiV Healthcare’s HIV Treatment 89 Percent More Effective than Truvada, Study Finds
ViiV Healthcare’s HIV Treatment 89 Percent More Effective than Truvada, Study Finds
ViiV Healthcare released interim results from a late-stage clinical trial that showed its long-acting investigational HIV treatment was 89 percent more effective in preventing infection among women than Truvada, Gilead Sciences’ daily oral pill.